Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research Units
Projects
Activities
Datasets
Equipment
Prizes
Press / Media
Search by expertise, name or affiliation
The Molecular and Cellular Immunology of Bladder Cancer and Disease Responses to BCG Therapy - Collection of Relevant Biospecimens
Bryan, Rik
(Principal Investigator)
Cancer and Genomic Sciences
Overview
Fingerprint
Research output
(1)
Project Details
Short title
The Molecular and Cellular Immunology of Bladder Cancer and Disease Responses to BCG Therapy - Collection of Relevant Biospecimens
Status
Finished
Effective start/end date
1/03/11
→
29/02/12
Funding
Cancer Research UK
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
interleukin-17
Agriculture & Biology
100%
urinary bladder neoplasms
Agriculture & Biology
92%
Parkinson disease
Agriculture & Biology
72%
mast cells
Agriculture & Biology
71%
Mycobacterium bovis
Medicine & Life Sciences
65%
Interleukin-17
Medicine & Life Sciences
64%
Mast Cells
Medicine & Life Sciences
59%
Urinary Bladder Neoplasms
Medicine & Life Sciences
58%
Research output
Research output per year
2017
2017
2017
1
Article
Research output per year
Research output per year
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer
Dowell, A.
,
Cobby, E.
,
Wen, K.
,
Devall, A.
,
During, V.
,
Anderson, J.
,
James, N.
,
Cheng, K.
,
Zeegers, M.
,
Bryan, R.
&
Taylor, G.
,
20 Sep 2017
,
In:
PLoS ONE.
12
,
9
, e0184841.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
interleukin-17
100%
urinary bladder neoplasms
92%
Parkinson disease
72%
mast cells
71%
Mycobacterium bovis
65%
10
Citations (Scopus)
112
Downloads (Pure)